CG:603669 Lionco Pharmaceutical Group Co., Ltd

Lionco Pharmaceutical Group Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells pharmaceuticals in China. The company offers nutrition, antimicrobial, antiviral, digestion, cardiovascular and cerebrovascular, detoxification, anti-tumor, and other products. It also operates research institutes that specialize in the research of chemical drugs, natural medicines, and biological drugs. Lionco Pharmaceutical Group Co., Ltd. was founded in 2003 and is based in Shannan, China.

9.48 CNY
As of 01/17/2022


Security Information
Category1:  Global Equity
Category2:  Common stocks
Category3:  Emerging markets
GICS sector:  Unknown
Industry:  Drug Manufacturers-Specialty &
Index country:  China
Country of incorporation:  China
IPO date:  05/28/2015
Stock exchange:    Shanghai Stock Exchange
Exchange country:   China
Market cap:   6,959,840,256 CNY
Current dividend yield:   2.07%
Sedol:      

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy